These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38910474)

  • 1. Evaluating the Performance of In silico Tools for PRRT2 Missense Variants.
    Sun H; Song W; Li B
    Comb Chem High Throughput Screen; 2024 Jun; ():. PubMed ID: 38910474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of performance of five bioinformatics software for the prediction of missense mutations].
    Chen Q; Dai C; Zhang Q; Du J; Li W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):625-8. PubMed ID: 27577208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Predictive
    Pshennikova VG; Barashkov NA; Romanov GP; Teryutin FM; Solov'ev AV; Gotovtsev NN; Nikanorova AA; Nakhodkin SS; Sazonov NN; Morozov IV; Bondar AA; Dzhemileva LU; Khusnutdinova EK; Posukh OL; Fedorova SA
    ScientificWorldJournal; 2019; 2019():5198931. PubMed ID: 31015822
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of the predictive accuracy of five in silico prediction tools, alone or in combination, and two metaservers to classify long QT syndrome gene mutations.
    Leong IU; Stuckey A; Lai D; Skinner JR; Love DR
    BMC Med Genet; 2015 May; 16():34. PubMed ID: 25967940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of 13 in silico pathogenicity methods on cancer-related variants.
    Yazar M; Ozbek P
    Comput Biol Med; 2022 Jun; 145():105434. PubMed ID: 35364305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis diagnostic accuracy of SNP-based pathogenicity detection tools: a case of UTG1A1 gene mutations.
    Galehdari H; Saki N; Mohammadi-Asl J; Rahim F
    Int J Mol Epidemiol Genet; 2013; 4(2):77-85. PubMed ID: 23875061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AI-derived comparative assessment of the performance of pathogenicity prediction tools on missense variants of breast cancer genes.
    Ahmad RM; Ali BR; Al-Jasmi F; Al Dhaheri N; Al Turki S; Kizhakkedath P; Mohamad MS
    Hum Genomics; 2024 Sep; 18(1):99. PubMed ID: 39256852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants.
    Ioannidis NM; Rothstein JH; Pejaver V; Middha S; McDonnell SK; Baheti S; Musolf A; Li Q; Holzinger E; Karyadi D; Cannon-Albright LA; Teerlink CC; Stanford JL; Isaacs WB; Xu J; Cooney KA; Lange EM; Schleutker J; Carpten JD; Powell IJ; Cussenot O; Cancel-Tassin G; Giles GG; MacInnis RJ; Maier C; Hsieh CL; Wiklund F; Catalona WJ; Foulkes WD; Mandal D; Eeles RA; Kote-Jarai Z; Bustamante CD; Schaid DJ; Hastie T; Ostrander EA; Bailey-Wilson JE; Radivojac P; Thibodeau SN; Whittemore AS; Sieh W
    Am J Hum Genet; 2016 Oct; 99(4):877-885. PubMed ID: 27666373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of in silico pathogenicity prediction tools for the classification of small in-frame indels.
    Cannon S; Williams M; Gunning AC; Wright CF
    BMC Med Genomics; 2023 Feb; 16(1):36. PubMed ID: 36855133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics.
    Ernst C; Hahnen E; Engel C; Nothnagel M; Weber J; Schmutzler RK; Hauke J
    BMC Med Genomics; 2018 Mar; 11(1):35. PubMed ID: 29580235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression Modeling and Meta-Analysis of Diagnostic Accuracy of SNP-Based Pathogenicity Detection Tools for UGT1A1 Gene Mutation.
    Rahim F; Galehdari H; Mohammadi-Asl J; Saki N
    Genet Res Int; 2013; 2013():546909. PubMed ID: 23997956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of mutation pathogenicity prediction tools on missense variants associated with 46,XY differences of sex development.
    Montenegro LR; Lerário AM; Nishi MY; Jorge AAL; Mendonca BB
    Clinics (Sao Paulo); 2021; 76():e2052. PubMed ID: 33503178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CoDP: predicting the impact of unclassified genetic variants in MSH6 by the combination of different properties of the protein.
    Terui H; Akagi K; Kawame H; Yura K
    J Biomed Sci; 2013 Apr; 20(1):25. PubMed ID: 23621914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of computational techniques for predicting non-synonymous single nucleotide variants pathogenicity.
    Hassan MS; Shaalan AA; Dessouky MI; Abdelnaiem AE; ElHefnawi M
    Genomics; 2019 Jul; 111(4):869-882. PubMed ID: 29842949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 16p11.2 deletion in patients with paroxysmal kinesigenic dyskinesia but without intellectual disability.
    Li W; Wang Y; Li B; Tang B; Sun H; Lai J; He N; Li B; Meng H; Liao W; Liu X
    Brain Behav; 2018 Nov; 8(11):e01134. PubMed ID: 30307717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of tools used to predict the impact of missense variants is hindered by two types of circularity.
    Grimm DG; Azencott CA; Aicheler F; Gieraths U; MacArthur DG; Samocha KE; Cooper DN; Stenson PD; Daly MJ; Smoller JW; Duncan LE; Borgwardt KM
    Hum Mutat; 2015 May; 36(5):513-23. PubMed ID: 25684150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRRT2 missense mutations cluster near C-terminus and frequently lead to protein mislocalization.
    Tsai MH; Nian FS; Hsu MH; Liu WS; Liu YT; Liu C; Lin PH; Hwang DY; Chuang YC; Tsai JW
    Epilepsia; 2019 May; 60(5):807-817. PubMed ID: 30980674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional study and pathogenicity classification of PRRT2 missense variants in PRRT2-related disorders.
    Zhao SY; Li LX; Chen YL; Chen YJ; Liu GL; Dong HL; Chen DF; Li HF; Wu ZY
    CNS Neurosci Ther; 2020 Jan; 26(1):39-46. PubMed ID: 31124310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. REVEL and BayesDel outperform other in silico meta-predictors for clinical variant classification.
    Tian Y; Pesaran T; Chamberlin A; Fenwick RB; Li S; Gau CL; Chao EC; Lu HM; Black MH; Qian D
    Sci Rep; 2019 Sep; 9(1):12752. PubMed ID: 31484976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1/2 missense mutations and the value of in-silico analyses.
    Sadowski CE; Kohlstedt D; Meisel C; Keller K; Becker K; Mackenroth L; Rump A; Schröck E; Wimberger P; Kast K
    Eur J Med Genet; 2017 Nov; 60(11):572-577. PubMed ID: 28807866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.